<DOC>
	<DOCNO>NCT01015001</DOCNO>
	<brief_summary>The primary outcome study evaluate effect low frequency subthreshold repetitive Transcranial Magnetic Stimulation apply left temporoparietal cortex patient refractory schizophrenia severity auditory hallucination . The secondary outcome evaluate effect rTMS protocol quality life , functionality general psychopathology .</brief_summary>
	<brief_title>A Pilot Double-blind Sham-controlled Trial Repetitive Transcranial Magnetic Stimulation Patients With Refractory Schizophrenia Treated With Clozapine</brief_title>
	<detailed_description>Seventeen patient DSM-IV TR diagnosis schizophrenia randomize two group . First group receive 20 session 20 minute low-frequency ( 1Hz ) rTMS apply leave temporoparietal cortex ( LTPC ) . Second group receive sham ( placebo ) stimulation LTPC period time . All patient consider refractory schizophrenia use least 400mg/day clozapine refer auditory hallucination occur least 5 time day .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Hallucinations</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>Patients DSM IV TR diagnose schizophrenia treatmentresistant auditory hallucination . Use least 400mg/day clozapine Men woman 18 65 year old Fertile woman must use adequate contraceptive method BPRS score least 27 Suicide risk Patients epilepsy , brain surgery and/or head trauma past , use cardiac pace maker metalic clip head Diagnose substance abuse/dependance Severe uncontrolled organic disease may interfere patient´s participation study Any reason , investigator´s opinion , might interfere patient´s participation study , non compliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>refractory schizophrenia</keyword>
	<keyword>rTMS</keyword>
	<keyword>auditory hallucination</keyword>
</DOC>